ARTICLE | Company News
BIO licenses Ramoplanin to GENE
October 9, 2001 7:00 AM UTC
Biosearch Italia (NMerc:BIO) granted exclusive North American development and marketing rights for Ramoplanin to Genome Therapeutics (GENE). Ramoplanin, an inhibitor of gram-positive bacterial cell wa...